—
C+
C+ The full Closelook — membership. Open the C+ overview

GE HealthCare Technologies Inc.（GEHC）— 同类公司组

数据截至2026-09-24 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

GE HealthCare Technologies Inc.的Closelook综合评分为43/100，在同类公司组内排名第9位（共9家）——组内评分最高的是Halozyme Therapeutics Inc（74/100）。

名称综合动量质量估值信号距52周高点
GEHC GE HealthCare Technologies Inc.43315255bear26.3%
DXCM DexCom Inc66858036neutral5.2%
GMED Globus Medical58216458bull27.1%
SECT-B.ST Sectra AB (publ)58666612bear21.5%
CEVI.ST CellaVision AB55696931bull10.6%
SOON.SW Sonova H Ag55867253bull2.4%
SYK Stryker Corporation51186545bear30.6%
HALO Halozyme Therapeutics Inc74969445ok1.4%
ARGX argenx NV ADR64747327ok10.3%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-09-24

Quick answers

GE HealthCare Technologies Inc.在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：DexCom Inc (DXCM)、Globus Medical (GMED)、Sectra AB (publ) (SECT-B.ST)、CellaVision AB (CEVI.ST)、Sonova H Ag (SOON.SW)、Stryker Corporation (SYK)、Halozyme Therapeutics Inc (HALO)、argenx NV ADR (ARGX)。

GEHC相对同类公司的评分如何？

GE HealthCare Technologies Inc.的综合评分为43/100，组内排名第9位（共9家），截至2026-09-24；组内最高综合评分为Halozyme Therapeutics Inc（74/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.